Business Context and Reporting Period
Company: ALPHA PRO TECH LTD
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 1996
Business Overview: The Company develops, manufactures, and markets disposable protective apparel, food industry products, infection control items, wound care products, and consumer goods. Operations are divided into four segments: Apparel, Food Industry, Mask and Shield, and Wound Care. The Company shifted strategy in late 1995 to focus on cleanroom apparel and food service products due to declining cash flows in its mask, shield, and wound care divisions.
Key Financial Metrics (Year Ended Dec 31, 1996)
| Metric | 1996 | 1995 |
|---|---|---|
| Operating Revenues | $14,863,000 | $13,031,000 |
| Gross Profit | $5,198,000 | $4,469,000 |
| Gross Margin | 35.0% | 34.3% |
| Net Loss | $(2,145,000) | $(5,971,000) |
| Loss Per Share | $(0.12) | $(0.36) |
| Current Assets | $5,614,000 | $4,860,000 |
| Current Liabilities | $3,414,000 | $3,166,000 |
| Working Capital | $2,200,000 | $1,694,000 |
| Cash and Equivalents | $275,000 | $344,000 |
| Long-Term Debt | $217,000 | $240,000 |
Cash Flow: Net cash used for operating activities was $298,000 in 1996, an improvement from $480,000 in 1995. Net cash used for investing activities was $460,000. Net cash provided by financing activities was $689,000.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 14.1% to $14.86 million, driven primarily by a 50.9% increase in the Apparel Division ($7.48 million vs. $4.95 million). This growth was facilitated by a new manufacturing facility in Nogales, Mexico.
- Segment Declines: Mask and eye shield sales decreased 3.3% to $5.04 million. Unreal Lambskin and related product sales dropped 18.1% to $2.35 million due to competitive pricing and the loss of a major distributor.
- Non-Cash Charges: The 1996 net loss included a $2,204,000 non-cash charge resulting from the exchange of 2,475,000 escrowed shares for new shares. Excluding this charge, the Company reported a net income of $59,000.
- Expense Management: Selling, general, and administrative (SG&A) expenses rose to $4.61 million (31% of sales) from $4.34 million (33% of sales). Interest expense decreased significantly to $279,000 from $563,000.
Guidance, Outlook, and Risks
- Strategic Focus: Management intends to maximize sales and profit by focusing on cleanroom apparel and food service industry products. The Company entered an exclusive distribution agreement with Chicopee, Inc. for food service shoe covers, requiring $11 million in purchases over 18 months to maintain exclusivity.
- Liquidity Outlook: The Company holds $275,000 in cash and has a $3,000,000 secured asset-based line of credit (with $1,331,000 available as of year-end). Management believes it has sufficient cash to finance known commitments for at least 24 months.
- Customer Concentration Risk: Sales to VWR Scientific Products (successor to Baxter) represented 42.9% of total sales in 1996. The loss of this customer would have a material adverse effect on the business.
- Legal Proceedings: The Company is defending a lawsuit filed by New-Invest, Inc., alleging damages of $1.248 million related to a private securities offering. The Company denies the allegations and intends to vigorously defend the action.
- Capital Expenditures: The Company anticipates additions to property and equipment of approximately $600,000 in 1997, contingent on success in the food industry.
Investor Verification Checklist
- Customer Dependency: Verify the stability of the relationship with VWR Scientific Products, which accounts for nearly 43% of revenue.
- Escrow Share Charge: Confirm the non-cash nature of the $2.2 million charge and its impact on the reported net loss versus operational performance.
- Food Service Expansion: Assess the progress of the Chicopee, Inc. distribution agreement and whether the $11 million purchase minimum is being met.
- Liquidity Position: Monitor the utilization of the $3 million asset-based credit line and the Company's ability to generate positive operating cash flow.
- Legal Exposure: Track the status of the New-Invest, Inc. litigation and potential financial impact.